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Purpose or Objective: Selecting good responders after 
chemoradiation (CRT) for locally advanced rectal cancer 
(LARC) could lead to the omission of total mesorectal 
excision (TME) in patients with pathologic complete response 
(pCR). In the current study, we assessed the value of several 
blood biomarkers associated with the fibrotic response to 
CRT (IGF-1, IGFBP-2, HGF & GDF-15) as markers for general 
fibro-inflammatory response and as tumor response 
predictors in a group of 80 patients. 
 
Material and Methods: ELISA analysis of IGF-1, IGFBP-2, HGF 
and GDF-15 was conducted on prospectively collected serum 
samples of 80 LARC patients on 3 time points (before, during, 
after CRT). The fibro-inflammatory response was scored on 
H&E sections of the resection specimen. Changes in 
concentration were analysed using a Kruskal-Wallis test. 
Correlation of concentration at each time point and the 
difference between these time points (Δ) with fibro-
inflammatory response and tumor response (pCR and ypT0-1) 
were assessed using a Mann-Whitney-U test. 
 
Results: Higher Growth Differentiation Factor 15 (GDF-15) 
concentration before CRT correlated with the presence of a 
fibro-inflammatory response (p = 0.04), but was not observed 
for the other proteins nor for GDF-15 at other time points.  
General increase in GDF-15 concentration during treatment 
(median 0.81 ng/ml before, 2.16 ng/ml during, 2.37 ng/ml 
after CRT; p <0.0001) was measured (Figure 1). Although no 
significant general concentration changes occurred for IGF-1, 
IGFBP-2 or HGF, we did find a correlation between the 
variation in expression of IGFBP-2 during treatment (ΔIGFBP-2 
TP3-TP2) with tumor response (pCR p = 0.02; ypT0-1 p = 
0.02). Other proteins did not correlate with tumor response. 
 
 
 
Conclusion: GDF-15 serum concentration increases during 
CRT for LARC and a higher concentration measured before 
start of treatment is correlated with the presence of a fibro-
inflammatory response. These results suggest that GDF-15 
could be used as an early predictor of fibro-inflammatory 
response and thereby indirectly as predictor for disease-free 
survival. This will be evaluated when follow-up data are 
available for this patient cohort.  
The correlation of variation in expression of IGFBP-2 with 
tumor response (pCR and ypT0-1) opens a novel possibility for 
selecting good responders to CRT. We aim to combine these 
findings with imaging analyses (DW-MRI, PET) at different 
time points during treatment to develop a predictive model 
for selecting LARC patients in whom surgery could be 
omitted. 
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Purpose or Objective: Hypoxia is a common feature in 
prostate cancer and is known to reduce the response to 
radiotherapy. Hypoxic modifiers can to a large extent 
overcome these obstacles, and a proper classification of 
tumors into hypoxic and non-hypoxic fractions is necessary. 
Previously our department has developed a gene profile 
consisting of 15 genes, which demonstrated prognostic and 
predictive impact for hypoxic modification in head and neck 
squamous cell carcinomas (HNSCC). In the current study we 
investigated the 15 gene profile in different prostate cancer 
cell lines. 
 
Material and Methods: For the in vitro experiments the 
prostate cancer cell lines investigated were PC-3, DU-145, 
and LNCaP. Cell lines were cultured under normoxic (21% O2) 
or hypoxic conditions (0% O2) for 24 hours, totRNA was 
extracted and gene expression levels measured by qPCR. 
Individual reference genes were selected (PSMC4, TBP, 
NDFIP1) and applied in the normalization of the relative 
expression levels, together with the reference genes 
previously used in the HNSCC study. For in vivo experiments, 
the PC3 cell line was inoculated on the flank of female NMRI 
nu/nu mice, whereas the LNCaP and DU-145 cell lines were 
inoculated on the flank of severely immunocompromised 
CIEA/NOG mice. Two hypoxia-sensitive tracers (18F-FAZA and 
Pimonidazole) were administered in order to determine 
hypoxic and non-hypoxic regions on excised tumor sections. 
These regions were isolated by laser-assisted microdissection, 
after which totRNA was extracted and gene expression levels 
measured by qPCR. 
 
Results: In the in vitro experiments, all prostate cancer cell 
lines had 14 of the 15 genes induced by hypoxia. The only 
discrepancy was ALDOA, which was not upregulated in the 
hypoxic cells. In vivo experiments are still ongoing but 
preliminary results from PC3 xenografts have been produced. 
These show a hypoxia induced upregulation in 10 out of the 
15 genes, of which 4 were significantly upregulated (ADM, 
ANKRD37, FAM162A, and LOX). 
 
Conclusion: In this study we investigated the 15 gene hypoxic 
profile in three different prostate cancer cell lines. A hypoxia 
dependent induction of genes was observed in both in vitro 
and in vivo experiments. From the performed experiments, 
and looking only at oxygen dependency, it appears that the 
gene profile could be suitable for prostate cancers as well as 
HNSCC. 
 
EP-2057  
Radiotoxicity prediction by gene expression profiling when 
simulating therapy in matched fibroblasts 
M.A. Schirmer
1Klinikum der Universität Göttingen, Radiotherapy and 
Radiation Oncology, Göttingen, Germany 
1, C.P.N. Mergler1, L.H. Droege1, M. Guhlich1, J. 
Gaedcke2, M. Ghadimi2, M. Rave-Fränk1 
2Klinikum der Universität Göttingen, General and Visceral 
Surgery, Göttingen, Germany 
 
Purpose or Objective: Acute radiotoxicity might put a vital 
threat to the patient and may require interruption or 
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preterm stop of the therapy thus jeopardizing the intended 
treatment outcome. Despite numerous research attempts 
there is still no robust feature established in clinical routine 
to predict radiotherapy-induced toxicity prior to therapy 
start. 
 
Material and Methods: The study cohort comprised 40 
patients who underwent neoadjuvant radiochemotherapy (N-
RCT) for rectal cancer (28x1.8 Gy, 5 times weekly, 
concomitant with two cycles 5-FU-based chemotherapy). 
From each of those patients dermal fibroblasts were cultured 
from skin specimen gained outside of the radiotherapy 
planning target volume at occasion of surgery conducted 
about six weeks upon N-RCT completion. Acute radiotoxicity 
was thoroughly monitored throughout the N-RCT series and 
documented according to CTC classification. Maximal acute 
toxicity (MAT) was defined by the highest CTC grade of the 
four items “cystitis”, “proctitis”, “enteritis”, and 
“dermatitis”. MAT was grouped into grades 0/1 (n=16), 2 
(n=16), and 3/4 (n=8). N-RCT was simulated in the cultured 
fibroblasts for five consecutive days (1.8 Gy each at d1-d5 
with addiation of 5-FU at a concentration reflecting clinical 
steady-state levels) followed by a 7-day wash-out period. 
Gene expression of nine candidate genes (CAT, CDKN1A, 
CTGF, SMAD2/3/4/7, TGFB1, TGFBR1) supposed to mediate 
early radiation-induced toxicity was ascertained by 
quantitative real time PCR. Samples for these RNA analyses 
were harvested at d2 and d5 (each 4 hours upon application 
of the radiation fraction) as well as at day 12 upon the wash-
out period. GAPDH and HPRT1 transcript levels served as 
reference. 
 
Results: MAT was related to radiation-induced expression 
changes of four of the considered genes in fibroblasts. The 
strongest impact was obtained for SMAD7 and CAT at d5. The 
higher the MAT score, the lower the induction of SMAD7 and 
CAT by radiation was (p=0.001 and 0.003). However, upon 
the wash-out period at d12 no statistical differences in 
dependence on the MAT score were seen anymore for these 
two genes. In contrast, a high MAT score was linked to low 
radiation-induced induction of CTGF (p=0.005) and to a faster 
decrease of the massively induced CDKN1A (p=0.03) at d12. 
At d2, a trend (p=0.06) for CAT in relation to MAT in the 
same direction as at d5 was noticed with no correlation of 
any of the other genes at this early time point. 
 
Conclusion: Radiation-induced expression changes in patient-
matched fibroblasts may serve as biomarkers to predict 
clinical radiotoxicity. Induction of SMAD7 and CAT may 
mitigate TGFbeta signalling and reactive oxygen species load 
thus saving normal tissue during radiotherapy. A protective 
role might also be attributed to sustained elevation of 
CDKN1A. The link between post-radiation induction of CTGF 
in fibroblasts and low MAT remains to be clarified. 
Understanding the mechanistic basis of these findings might 
pave the way for better protection of irradiated normal 
tissue. 
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Purpose or Objective: Erectile dysfunction (ED) is one of the 
most common complications encountered after radiotherapy 
in prostate cancer patients. The goal of this study was to 
investigate whether single nucleotide polymorphisms (SNPs) 
are associated with late ED in men treated with radiotherapy 
for prostate cancer. To this end, we designed a novel 
machine learning-based multi-SNP model using a genome-
wide association study (GWAS) dataset. 
 
Material and Methods: We analyzed 236 evaluable patients 
with at least one year of follow-up for the development of 
ED. The severity of ED was assessed using either the patient-
administered Sexual Health Inventory for Men (SHIM) or the 
clinician-assigned Mount Sinai Erectile Function (MSEF) 
scoring schema. There were 133 patients with Grade 2 or 
more ED. For our analysis, the cohort was split into two 
groups (cases/controls: MSEF 0,1 / 2,3; cases/controls: SHIM 
≤7 / ≥16). Genome-wide SNP data were available from 
Affymetrix Genome-Wide Human SNP Array 6.0. After a 
quality test including SNP missing rate>5%, minor allele 
frequency (MAF)<5%, and Hardy-Weinberg equilibrium 
(p<10E-5), 613,496 SNPs remained. 
For the validation purpose of our proposed model, the 
dataset was split into a training dataset (2/3 of samples) and 
a validation dataset (1/3 of samples). Our model building 
process was performed using the bootstrapped data from the 
training dataset. Our idea is to convert the binary outcomes 
into preconditioned continuous outcomes based on normal 
tissue complication probability (NTCP) using principal 
component analysis (PCA) and logistic regression. The 
preconditioned outcomes were used in the model building 
process using random forest regression. Then, the model was 
tested using the validation dataset. The final predicted 
outcomes were compared with the original binary outcomes 
to estimate the predictive performance. We iterated this 
process 100 times and the performance was averaged. We 
compared the performance of our proposed method 
(preconditioning random forest regression: PRFR) with other 
methods including preconditioning lasso (PL), lasso logistic 
regression (LLR), and random forest classification (RFC). 
 
Results: Univariate analysis was performed using the training 
dataset. With a threshold of p=0.001, 367 SNPs remained. 
These SNPs were fed into our model. As shown in Figure (A), 
the averaged performance with the validation dataset was 
AUC=0.62, which is better than other methods: RFC (0.57), 
PL (0.58), and LLR (0.57). The 79 patients in the validation 
dataset were binned into 6 groups according to the predicted 
risk of ED. Figure (B) shows the comparison of the model-
predicted incidence of ED with observed incidence.  
 
Conclusion: Our machine learning-based multi-SNP model 
showed the potential to better predict the radiation-induced 
late ED. However, we need to validate our model using other 
datasets. 
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Purpose or Objective: Tumor hypoxia, a common feature of 
locally advanced head and neck cancer (HNSCC), is 
associated with higher malignancy and increased 
radioresistance. The decrease of tumor hypoxia during 
